Cargando…

Human Papillomavirus Mutational Insertion: Specific Marker of Circulating Tumor DNA in Cervical Cancer Patients

INTRODUCTION: In most cases of cervical cancers, HPV DNA is integrated into the genome of carcinoma cells. This mutational insertion constitutes a highly specific molecular marker of tumor DNA for every patient. Circulating tumor DNA (ctDNA) is an emerging marker of tumor dynamics which detection re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campitelli, Maura, Jeannot, Emmanuelle, Peter, Martine, Lappartient, Emmanuelle, Saada, Stéphanie, de la Rochefordière, Anne, Fourchotte, Virginie, Alran, Séverine, Petrow, Peter, Cottu, Paul, Pierga, Jean-Yves, Lantz, Olivier, Couturier, Jérôme, Sastre-Garau, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3427328/ https://www.ncbi.nlm.nih.gov/pubmed/22937045 http://dx.doi.org/10.1371/journal.pone.0043393

Ejemplares similares

Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus‐associated invasive carcinoma
por: Jeannot, Emmanuelle, et al.
Publicado: (2016)

Pre-operative Concomitant Radio-chemotherapy in Bulky Carcinoma of the Cervix: A Single Institution Study
por: de la Rochefordiere, Anne, et al.
Publicado: (2008)

Outcome in Advanced Ovarian Cancer following an Appropriate and Comprehensive Effort at Upfront Cytoreduction: A Twenty-Year Experience in a Single Cancer Institute
por: Marszalek, Anne, et al.
Publicado: (2010)

A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer
por: Meyniel, Jean-Philippe, et al.
Publicado: (2010)

Long-Term Prognostic Performance of Ki67 Rate in Early Stage, pT1-pT2, pN0, Invasive Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2013)

Mechanistic signatures of HPV insertions in cervical carcinomas
por: Holmes, Allyson, et al.
Publicado: (2016)

The Molecular Subtype Classification Is a Determinant of Sentinel Node Positivity in Early Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2011)

Human papillomavirus (HPV) insertional mutation as a dynamic & specific tumour biomarker in HPV-associated carcinoma
por: Sastre-Garau, Xavier
Publicado: (2015)

HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports
por: Arfi, Alexandra, et al.
Publicado: (2019)

Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2017)

Genome-wide profiling of human papillomavirus DNA integration in liquid-based cytology specimens from a Gabonese female population using HPV capture technology
por: Nkili-Meyong, Andriniaina Andy, et al.
Publicado: (2019)

Mechanistic Signatures of Human Papillomavirus Insertions in Anal Squamous Cell Carcinomas
por: Morel, Adeline, et al.
Publicado: (2019)

Reasons of not having breast reconstruction: a historical cohort of 1937 breast cancer patients undergoing mastectomy
por: Héquet, Delphine, et al.
Publicado: (2013)

Non-Sentinel Lymph Node Metastasis Prediction in Breast Cancer with Metastatic Sentinel Lymph Node: Impact of Molecular Subtypes Classification
por: Reyal, Fabien, et al.
Publicado: (2012)

Genetic profiles of cervical tumors by high-throughput sequencing for personalized medical care
por: Muller, Etienne, et al.
Publicado: (2015)

Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection
por: Cacheux, Wulfran, et al.
Publicado: (2016)

Unexpected behavioural consequences of preterm newborns' clothing
por: Durier, Virginie, et al.
Publicado: (2015)

Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2012)

Correction: Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2012)

Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2015)

Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study
por: Bidard, François-Clément, et al.
Publicado: (2013)

Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer
por: Jeannot, Emmanuelle, et al.
Publicado: (2021)

Impact of the COVID-19 Outbreak on the Management of Patients with Cancer
por: Raymond, Eric, et al.
Publicado: (2020)

Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomas
por: Sablin, Marie-Paule, et al.
Publicado: (2016)

Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2016)

HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?
por: Vincent-Salomon, A, et al.
Publicado: (2007)

Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy
por: Baulies, S, et al.
Publicado: (2015)

Epidermodysplasia Verruciformis: Inborn Errors of Immunity to Human Beta-Papillomaviruses
por: de Jong, Sarah J., et al.
Publicado: (2018)

Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy
por: Chauveinc, L, et al.
Publicado: (2003)

HPV insertional pattern as a personalized tumor marker for the optimized tumor diagnosis and follow-up of patients with HPV-associated carcinomas: a case report
por: Harlé, Alexandre, et al.
Publicado: (2019)

Are ipsilateral breast tumour invasive recurrences in young (⩽40 years) women more aggressive than their primary tumours?
por: Sigal-Zafrani, B, et al.
Publicado: (2007)

HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer
por: Cabel, L., et al.
Publicado: (2021)

Pathology of HPV-Associated Head and Neck Carcinomas: Recent Data and Perspectives for the Development of Specific Tumor Markers
por: Sastre-Garau, Xavier, et al.
Publicado: (2020)

Population‐specific dynamics and selection patterns of transposable element insertions in European natural populations
por: Lerat, Emmanuelle, et al.
Publicado: (2019)

Human Papillomavirus Infection and EGFR Exon 20 Insertions in Sinonasal Inverted Papilloma and Squamous Cell Carcinoma
por: Hirakawa, Hitoshi, et al.
Publicado: (2023)

Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma
por: Daveau, C, et al.
Publicado: (2014)

Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based models
por: Laas, E, et al.
Publicado: (2015)

Prenatal Diagnosis of a 2.5 Mb De Novo 17q24.1q24.2 Deletion Encompassing KPNA2 and PSMD12 Genes in a Fetus with Craniofacial Dysmorphism, Equinovarus Feet, and Syndactyly
por: Naud, Marie-Emmanuelle, et al.
Publicado: (2017)

Dual time point [(18)F]FLT-PET for differentiating proliferating tissues vs non-proliferating tissues
por: Lovinfosse, Pierre, et al.
Publicado: (2019)

Sentinel Lymph Node Biopsy in Uterine Cancer: Time for a Modern Approach
por: Laas, Enora, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qkits5o0bs17lojlma9suaho3n